OMIX

A non-comparative of ruxolitinib in polycythemia vera subjects who are resistant to or intolerant of hydroxyurea or Interferon alpha

OMIX005847

1Summary
Title A non-comparative of ruxolitinib in polycythemia vera subjects who are resistant to or intolerant of hydroxyurea or Interferon alpha
Description The emerging efficacy and safety profile for ruxolitinib supports further studies in Chinese PV subjects who demonstrate resistance or intolerance to HU or IFN-α therapy. The purpose of this trial is to demonstrate clinically meaningful responses in PV subjects receiving ruxolitinib
Organism Homo sapiens
Data Type Other Type of Genomic Data
Data Accessibility Controlled-access
BioProject PRJCA023662
Release Date 2024-02-20
Submitter yating liu (liuyating@ihcams.ac.cn)
Organization Institute of hematology&Blood diseases hospital, Chinese academy of medical sciences&Peking union medical college
Submission Date 2024-02-19
2Files & Download

The data cannot be downloaded as it has not yet been registered in the Human Genetic Resource Management Platform of MOST.

File ID File Title Number/Samples File Type File Size File Suffix Download Times Download
OMIX005847-01 ruxolitinib in polycythemia are resistant to or intolerant of hydroxyurea or Interferon alpha-Data -final 34 Other Type of Genomic Data 163.9 KB xlsx 0 Unavailable

Request for this Data View All Released Data of OMIX